Literature DB >> 10820376

Survival and cytokine polarization of naive CD4(+) T cells in vitro is largely dependent on exogenous cytokines.

S Z Ben-Sasson1, K Makedonski, J Hu-Li, W E Paul.   

Abstract

Naive CD4(+) T cells differ from memory cells by their heightened expression of the disialoceramide recognized by antibody 3G11. 3G11(bright) cells respond well to immobilized anti-CD3 / anti-CD28 and to their cognate antigens but produce little or no IFN-gamma or IL-4 "acutely" and undergo cell death even in the presence of IL-2. They can be rescued by IL-4, IL-6 or IL-12. IL-6 is particularly notable since it is neutral in regard to Th1 / Th2 priming, allowing an assessment of the role of endogenous IL-4 in priming for IL-4 production. Naive TCR-transgenic BALB / c scid T cells cultured with an ovalbumin peptide and IL-4(- / -) antigen-presenting cells in the presence of IL-6 showed a modest degree of priming for IL-4 production if both IFN-gamma and IL-12 were neutralized. This priming is far less than that observed if IL-4 is added to the priming culture. These results indicate that IL-4 production as a result of TCR engagement is sufficient for only a minor component of the polarization observed when unseparated BALB / c CD4 T cell populations are primed or when IL-4 is intentionally added to the priming culture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820376     DOI: 10.1002/(SICI)1521-4141(200005)30:5<1308::AID-IMMU1308>3.0.CO;2-I

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  NK T cells are a source of early interleukin-4 following infection with third-stage larvae of the filarial nematode Brugia pahangi.

Authors:  Paul Balmer; Eileen Devaney
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Antigen challenge leads to in vivo activation and elimination of highly polarized TH1 memory T cells.

Authors:  Nobuki Hayashi; Dacai Liu; Booki Min; Shlomo Z Ben-Sasson; William E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

3.  The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity.

Authors:  Roslyn A Kemp; B Thomas Bäckström; Franca Ronchese
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

4.  Indoleamine 2,3-dioxygenase and metabolites protect murine lung allografts and impair the calcium mobilization of T cells.

Authors:  Khadija Iken; Kaifeng Liu; Hanzhong Liu; Peyman Bizargity; Liqing Wang; Wayne W Hancock; Gary A Visner
Journal:  Am J Respir Cell Mol Biol       Date:  2012-04-19       Impact factor: 6.914

5.  Interleukin 2 plays a central role in Th2 differentiation.

Authors:  Javier Cote-Sierra; Gilles Foucras; Liying Guo; Lynda Chiodetti; Howard A Young; Jane Hu-Li; Jinfang Zhu; William E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-05       Impact factor: 11.205

6.  Interleukin-6 expands homeostatic space for peripheral T cells.

Authors:  Changwan Hong; Anna S Nam; Hilary R Keller; Davinna L Ligons; Joo-Young Park; Hee-Won Yoon; Joseph J Park; Megan A Luckey; Jung-Hyun Park
Journal:  Cytokine       Date:  2013-08-26       Impact factor: 3.861

7.  Differential T cell function and fate in lymph node and nonlymphoid tissues.

Authors:  Nicola L Harris; Victoria Watt; Franca Ronchese; Graham Le Gros
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

8.  Effector/memory CD4 T cells making either Th1 or Th2 cytokines commonly co-express T-bet and GATA-3.

Authors:  Arundhoti Das; Vidya Ranganathan; Danish Umar; Shipra Thukral; Anna George; Satyajit Rath; Vineeta Bal
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

9.  Transgene IL-6 enhances DC-stimulated CTL responses by counteracting CD4+25+Foxp3+ regulatory T cell suppression via IL-6-induced Foxp3 downregulation.

Authors:  Kalpana Kalyanasundaram Bhanumathy; Bei Zhang; Khawaja Ashfaque Ahmed; Mabood Qureshi; Yufeng Xie; Min Tao; Xin Tan; Jim Xiang
Journal:  Int J Mol Sci       Date:  2014-03-31       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.